JP TSE 4882 Pharmaceutical

Perseus Proteomics Inc.

株式会社ペルセウスプロテオミクス

Fiscal year ends
Mar
Latest results
FY ending Mar 2026
Employees
35
Revenue
¥136M
≈ $858K
Net income
−¥718M
≈ −$4.5M
Income taxes paid
¥3.2M
≈ $20K
Total assets
¥1.6B
≈ $10.3M
Equity ratio
75.0%
 

Ranked #3,883 among listed Japanese companies by corporate taxes paid.

US dollar amounts use ¥158.0 per dollar.

Annual results

Fiscal yearRevenueNet incomeTax expenseTaxes paidTotal assetsNet assetsEquity ratioSource
Mar 2026¥136M−¥718M ¥1.9M¥3.2M ¥1.6B¥1.2B75.0% EDINET
Mar 2025¥120M−¥905M ¥2.5M¥1.9M ¥1.8B¥1.4B78.8% EDINET
Mar 2024¥100M−¥1.1B —— ¥1.7B¥1.4B82.6% EDINET
Mar 2023¥94.2M−¥787M —— ¥2.6B¥2.4B93.4% EDINET
Mar 2022¥71.9M−¥599M —— ¥3.3B¥3.2B95.5% EDINET

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ(同業比較・役員)

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.

World rankings